Tags

Type your tag names separated by a space and hit enter

Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients.
J Heart Lung Transplant. 2000 Feb; 19(2):215-9.JH

Abstract

Orthotopic heart transplant recipients need immunosuppressive treatment and are at an increased risk for opportunistic infections such as Malassezia folliculitis. During a 4-month period (July to October 1990), 11 such cases were identified and treated; all were male with mean age of 43+/-9 years and on standard triple immunosuppressive therapy. Skin scrapings in potassium hydroxide (KOH) preparation with microscopy and/or culture identified either Malassezia furfur or Malassezia pachydermatis as the etiologic agent. A treatment with topical preparation (clotrimazole 1% and selenium sulfide lotion) was effective in 6 patients, whereas the rest received systemic fluconazole treatment with satisfactory outcome; all lesions were resolved within 3 weeks. Fluconazole appears to be an effective agent with excellent therapeutic outcome when administered for 3 weeks.

Authors+Show Affiliations

Department of Medicine, Temple University Health Sciences Center, School of Medicine, Philadelphia, Pennsylvania 19140, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10703699

Citation

Rhie, S, et al. "Clinical Features and Treatment of Malassezia Folliculitis With Fluconazole in Orthotopic Heart Transplant Recipients." The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation, vol. 19, no. 2, 2000, pp. 215-9.
Rhie S, Turcios R, Buckley H, et al. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant. 2000;19(2):215-9.
Rhie, S., Turcios, R., Buckley, H., & Suh, B. (2000). Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation, 19(2), 215-9.
Rhie S, et al. Clinical Features and Treatment of Malassezia Folliculitis With Fluconazole in Orthotopic Heart Transplant Recipients. J Heart Lung Transplant. 2000;19(2):215-9. PubMed PMID: 10703699.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. AU - Rhie,S, AU - Turcios,R, AU - Buckley,H, AU - Suh,B, PY - 2000/3/7/pubmed PY - 2000/3/18/medline PY - 2000/3/7/entrez SP - 215 EP - 9 JF - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation JO - J. Heart Lung Transplant. VL - 19 IS - 2 N2 - Orthotopic heart transplant recipients need immunosuppressive treatment and are at an increased risk for opportunistic infections such as Malassezia folliculitis. During a 4-month period (July to October 1990), 11 such cases were identified and treated; all were male with mean age of 43+/-9 years and on standard triple immunosuppressive therapy. Skin scrapings in potassium hydroxide (KOH) preparation with microscopy and/or culture identified either Malassezia furfur or Malassezia pachydermatis as the etiologic agent. A treatment with topical preparation (clotrimazole 1% and selenium sulfide lotion) was effective in 6 patients, whereas the rest received systemic fluconazole treatment with satisfactory outcome; all lesions were resolved within 3 weeks. Fluconazole appears to be an effective agent with excellent therapeutic outcome when administered for 3 weeks. SN - 1053-2498 UR - https://www.unboundmedicine.com/medline/citation/10703699/Clinical_features_and_treatment_of_Malassezia_folliculitis_with_fluconazole_in_orthotopic_heart_transplant_recipients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1053-2498(99)00123-0 DB - PRIME DP - Unbound Medicine ER -